{"id":19702,"date":"2019-03-14T08:30:23","date_gmt":"2019-03-14T08:30:23","guid":{"rendered":"http:\/\/wames.org.uk\/cms-english\/?p=19702"},"modified":"2019-03-14T08:41:12","modified_gmt":"2019-03-14T08:41:12","slug":"epstein-barr-virus-induced-gene-2-upregulation-identifies-a-particular-subtype-of-cfs-me","status":"publish","type":"post","link":"https:\/\/wames.org.uk\/cms-english\/epstein-barr-virus-induced-gene-2-upregulation-identifies-a-particular-subtype-of-cfs-me\/","title":{"rendered":"Epstein-Barr virus induced gene-2 upregulation identifies a particular subtype of CFS\/ME"},"content":{"rendered":"<h3><a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2019.00059\/full\" target=\"_blank\" rel=\"noopener noreferrer\">Epstein-Barr virus induced gene-2 upregulation identifies a particular subtype of Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis<\/a>, by <a href=\"https:\/\/me-pedia.org\/wiki\/Jonathan_Kerr\" target=\"_blank\" rel=\"noopener noreferrer\">Jonathan R Kerr<\/a> <span style=\"text-decoration: underline;\">in<\/span> <em>Frontiers in Pediatrics,<\/em> 13 March 2019<\/h3>\n<p>&nbsp;<\/p>\n<p><strong>Research abstract:<\/strong><\/p>\n<p><a href=\"http:\/\/wames.org.uk\/cms-english\/2019\/03\/epstein-barr-virus-induced-gene-2-upregulation-identifies-a-particular-subtype-of-cfs-me\/dr-jonathan-kerr\/\" rel=\"attachment wp-att-20079\"><img data-recalc-dims=\"1\" decoding=\"async\" class=\"alignright size-medium wp-image-20079 lazyload\" data-src=\"https:\/\/i0.wp.com\/wames.org.uk\/cms-english\/wp-content\/uploads\/2019\/03\/Dr-Jonathan-Kerr-300x240.jpg?resize=300%2C240\" alt=\"\" width=\"300\" height=\"240\" data-srcset=\"https:\/\/i0.wp.com\/wames.org.uk\/cms-english\/wp-content\/uploads\/2019\/03\/Dr-Jonathan-Kerr.jpg?resize=300%2C240&amp;ssl=1 300w, https:\/\/i0.wp.com\/wames.org.uk\/cms-english\/wp-content\/uploads\/2019\/03\/Dr-Jonathan-Kerr.jpg?resize=150%2C120&amp;ssl=1 150w, https:\/\/i0.wp.com\/wames.org.uk\/cms-english\/wp-content\/uploads\/2019\/03\/Dr-Jonathan-Kerr.jpg?w=400&amp;ssl=1 400w\" data-sizes=\"(max-width: 300px) 100vw, 300px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 300px; --smush-placeholder-aspect-ratio: 300\/240;\" \/><\/a>Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis (CFS\/ME) is a chronic<br \/>\nmultisystem disease characterised by a variety of symptoms, and exhibits various features of an autoimmune-like disease. Subtypes are well recognised but to date are difficult to identify objectively.<\/p>\n<p>The disease may be triggered by infection with a variety of micro-organisms, including Epstein-Barr virus (EBV). A subset of CFS\/ME patients exhibit <a href=\"https:\/\/www.researchgate.net\/post\/What_do_downregulation_and_upregulation_mean\" target=\"_blank\" rel=\"noopener noreferrer\">up regulation<\/a> of EBV virus induced gene 2 (EBI2) mRNA in peripheral blood mononuclear cells (PBMC), and these patients appear to have a more severe disease phenotype and lower levels of EBNA1 IgG. EBI2 is induced by EBV infection and has been found to be upregulated in a variety of<br \/>\nautoimmune diseases.<\/p>\n<p>EBI2 is a critical gene in immunity and central nervous system function; it is a negative regulator of the innate immune response in monocytes. Its heterogeneous expression in CFS\/ME could explain the variable occurrence of a variety of immune and neurological abnormalities which are encountered in patients with CFS\/ME.<\/p>\n<p>The EBI2 subtype occurred in 38-55% CFS\/ME patients in our studies. Further work is required to confirm the role of EBV and of EBI2 and its oxysterol ligands in CFS\/ME, and to identify the most practical means to identify patients of the EBI subtype. There are two EBI2 <a href=\"https:\/\/en.wikipedia.org\/wiki\/Receptor_antagonist\" target=\"_blank\" rel=\"noopener noreferrer\">antagonists<\/a> currently in development, and these may hold promise for the treatment of CFS\/ME patients of the EBI subtype.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Epstein-Barr virus induced gene-2 upregulation identifies a particular subtype of Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis, by Jonathan R Kerr in Frontiers in Pediatrics, 13 March 2019 &nbsp; Research abstract: Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis (CFS\/ME) is a chronic multisystem disease characterised by &hellip; <a href=\"https:\/\/wames.org.uk\/cms-english\/epstein-barr-virus-induced-gene-2-upregulation-identifies-a-particular-subtype-of-cfs-me\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[4905,4907,4906,224,3210],"class_list":["post-19702","post","type-post","status-publish","format-standard","hentry","category-news","tag-dr-jonthan-kerr","tag-ebi2-antagonists","tag-ebi2-gene","tag-epstein-barr-virus","tag-sub-groups"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p5qkYK-57M","_links":{"self":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/19702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/comments?post=19702"}],"version-history":[{"count":5,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/19702\/revisions"}],"predecessor-version":[{"id":20085,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/posts\/19702\/revisions\/20085"}],"wp:attachment":[{"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/media?parent=19702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/categories?post=19702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wames.org.uk\/cms-english\/wp-json\/wp\/v2\/tags?post=19702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}